Pelvic Pain clinical trials

Explore recruiting pelvic pain clinical trials.

Recruiting pelvic pain studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Pelvic Pain trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Esketamine As treatment for chronic pain due to endometrioSis: a RCT studY

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 2a/b, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multicenter, Clinical Study to Evaluate the Efficacy and Safety of OG-6219 in 3 Dose Levels, in Women 18 to 49 Years of Age with Moderate to Severe Endometriosis-related Pain

Bulgaria, Latvia, Germany, Italy, Czechia, Belgium +4 more

Therapeutic exploratory (Phase II) EU CTIS Study details

The effect of cabergoline in infertile women on peritoneal endometriosis related dysmenorrhea, chronic pelvic pain and fertility

Finland

Therapeutic use (Phase IV) EU CTIS Study details

Evaluation of the Analgesic Effect of Intramyometrial Botulinum Toxin Injection via Hysteroscopy in pelvic pain suggestive of dysmenorrhea: A Prospective, Multicenter, Double-Blind, Randomized Placebo-Controlled Study. HYSTEROXINE Study

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Botulinumtoxin type A for treatment of Chronic Pelvic Pain Syndrome (CPPS): a phase 3 randomized, double blind, placebo-controlled, multi-center study

Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

CARESS Study: Cabergoline for the Reduction of Endometriosis Symptoms and Lesion Size

Spain

Phase III and phase IV (Integrated) EU CTIS Study details

Pelvic Pain trials by city

Pelvic Pain in Toronto Pelvic Pain in Vancouver Pelvic Pain in Montreal Pelvic Pain in Calgary Pelvic Pain in Edmonton Pelvic Pain in Ottawa Pelvic Pain in Winnipeg Pelvic Pain in Quebec City Pelvic Pain in Hamilton Pelvic Pain in Kitchener Pelvic Pain in London Pelvic Pain in Halifax Pelvic Pain in New York Pelvic Pain in Los Angeles Pelvic Pain in Chicago Pelvic Pain in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease